BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22105451)

  • 1. Short-term, high-dose statins in the prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Zhou Y; Yuan WJ; Zhu N; Wang L
    Clin Nephrol; 2011 Dec; 76(6):475-83. PubMed ID: 22105451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of short-term high-dose statins on the prevention of contrast-induced nephropathy in patients undertaking coronary angiography: a systematic review and meta-analysis].
    Zhou Y; Yuan WJ
    Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):942-6. PubMed ID: 22333127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.
    Liang M; Yang S; Fu N
    Medicine (Baltimore); 2017 Jul; 96(27):e7384. PubMed ID: 28682890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
    Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Zhang T; Shen LH; Hu LH; He B
    Am J Nephrol; 2011; 33(4):344-51. PubMed ID: 21430372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.
    Li Y; Liu Y; Fu L; Mei C; Dai B
    PLoS One; 2012; 7(4):e34450. PubMed ID: 22511942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis.
    Zhang BC; Li WM; Xu YW
    Can J Cardiol; 2011; 27(6):851-8. PubMed ID: 21944277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Hydroxy-3-methylglutaryl-CoA reductase enzyme inhibitors for prevention of contrast-induced nephropathy: a meta-analysis of prospective randomized controlled studies.
    Briasoulis A; Mallikethi-Reddy S; Sharma S; Briasouli AA; Afonso L
    Am J Ther; 2015; 22(6):e158-66. PubMed ID: 25187093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis.
    Zhou YL; Chen LQ; Du XG
    Clinics (Sao Paulo); 2021; 76():e1876. PubMed ID: 33787670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials.
    Barbieri L; Verdoia M; Schaffer A; Nardin M; Marino P; De Luca G
    J Thromb Thrombolysis; 2014 Nov; 38(4):493-502. PubMed ID: 24705677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
    Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
    Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
    Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
    Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statins in preventing contrast-induced nephropathy: an updated meta-analysis.
    Xie H; Ye Y; Shan G; Zhang S; Fang Q; Yang D; Zeng Y
    Coron Artery Dis; 2014 Nov; 25(7):565-74. PubMed ID: 25036858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
    Subramaniam RM; Suarez-Cuervo C; Wilson RF; Turban S; Zhang A; Sherrod C; Aboagye J; Eng J; Choi MJ; Hutfless S; Bass EB
    Ann Intern Med; 2016 Mar; 164(6):406-16. PubMed ID: 26830221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
    Li H; Wang C; Liu C; Li R; Zou M; Cheng G
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
    Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
    Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
    Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A network meta-analysis on randomized trials focusing on the preventive effect of statins on contrast-induced nephropathy.
    Peruzzi M; De Luca L; Thomsen HS; Romagnoli E; D'Ascenzo F; Mancone M; Sardella G; Lucisano L; Abbate A; Frati G; Biondi-Zoccai G
    Biomed Res Int; 2014; 2014():213239. PubMed ID: 25276771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.